MedTrace Logo

Safety and Efficacy of SINOMED SR for Endovascular Treatment of Acute Ischemic Stroke

NCT04973332 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 218

Last updated 2026-02-27

Study results available
· View outcomes & findings →

Summary

A prospective, multicenter, randomized controlled, non-inferiority study to investigate the effectiveness and safety of SINOMED SR for endovascular treatment of acute ischemic stroke

Conditions

  • Ischemic Stroke, Acute
  • Brain Diseases
  • Cerebrovascular Disorders

Interventions

DEVICE

Intracranial thrombectomy stent

Intracranial thrombectomy stents for ischemic stroke patients within 24 hours of symptom onset

Sponsors & Collaborators

  • The General Hospital of Eastern Theater Command

    collaborator OTHER

  • Sinomed Neurovita Technology Inc.

    lead INDUSTRY

Principal Investigators

  • Xinfeng Liu · General Hospital of Eastern Theater Command, PLA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-08
Primary Completion
2022-04-07
Completion
2022-06-24

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04973332 on ClinicalTrials.gov